Drug-Induced Pyoderma Gangrenosum: A Review
- 17 June 2017
- journal article
- review article
- Published by Springer Nature in American Journal of Clinical Dermatology
- Vol. 19 (1) , 67-77
Abstract
Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis that may be caused by an adverse drug reaction. We discuss the clinical presentation and outcomes of 52 cases of drug-induced PG reported to date in the literature. We conducted our literature search for case reports of drug-induced PG using keywords on PubMed and Medical Subject Heading (MeSH) terms on MEDLINE and EMBASE. To assess the probability that each case of PG was related to drug therapy, we used the Naranjo criteria. We identified 44 studies in the literature, with a total of 52 cases of drug-induced PG. The mean Naranjo score for cocaine-induced PG (n = 13) was 9.4, indicating a definite adverse drug reaction, while the mean Naranjo scores for isotretinoin (n = 5), propylthiouracil (n = 5), and sunitinib (n = 5) were 6.2, 6.8, and 7.4, respectively, indicating probable adverse drug reactions. Drugs should be considered as a possible triggering event whenever PG is diagnosed, and clinicians should particularly consider this in patients taking isotretinoin, propylthiouracil, or sunitinib, as well as in patients with a history of cocaine use.Keywords
This publication has 47 references indexed in Scilit:
- Imatinib induced pyoderma gangrenosumJournal of Postgraduate Medicine, 2013
- Ciprofloxacin induced pyoderma gangrenosumIndian Dermatology Online Journal, 2011
- A Case of p-ANCA-Positive Propylthiouracil-Induced Pyoderma GangrenosumAnnals of Dermatology, 2010
- Development of pyoderma gangrenosum during therapy with infliximabJournal of Dermatological Case Reports, 2009
- Pyoderma gangrenosum following isotretinoin therapy for acne nodulocysticInternational Journal of Dermatology, 2008
- Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritisClinical Rheumatology, 2007
- Pyoderma gangrenosum – a reviewOrphanet Journal of Rare Diseases, 2007
- Pyoderma gangrenosum associated with isotretinoin therapyJournal of the American Academy of Dermatology, 2006
- Pyoderma gangrenosum complicating pegylated granulocyte colony-stimulating factor in Hodgkin lymphomaBritish Journal of Haematology, 2006
- Pyoderma Gangrenosum Following Cytosine Arabinoside, Aclarubicin and Granulocyte Colony-Stimulating Factor Combination Therapy in Myelodysplastic Syndrome.Internal Medicine, 1998